文献速递腹部技术与安全US

肝动脉增强流速指数与代谢功能障碍相关脂肪性肝病中的脂肪变性和纤维化

Hepatic artery augmented velocity index and steatosis/fibrosis in MAFLD.
PubMed 文献 · Abdom Radiol (NY) · 2025-10-06

这项回顾性研究纳入197例接受肝胆超声、剪切波弹性成像和多普勒超声的MAFLD患者,发现肝动脉增强流速指数(HAVI)随脂肪变分级加重而显著升高,且与肝硬度(kPa)呈强正相关(r=0.66),而肝动脉阻力指数(HARI)无此差异;作者认为HAVI可作为多普勒衍生参数进一步研究,以支持MAFLD肝实质和微血管改变的无创评估。

要点

  • HAVI随脂肪变分级加重显著升高(p<0.01),HARI在各分级间无差异。
  • HAVI与肝硬度kPa呈强正相关(r=0.66,p<0.01)。
  • HAVI与ALT、AST、GGT呈中度相关,与血小板、白蛋白、甘油三酯无显著相关。

核心结论

  • HAVI与脂肪变严重程度及无创纤维化标志物显著相关,而HARI在本研究中未观察到此类关系。
  • 这些初步发现提示HAVI可作为潜在的多普勒衍生参数进一步研究,以支持MAFLD患者肝实质和微血管改变的无创评估。

研究设计与样本

  • 回顾性研究,纳入197例于2021年1月至2023年11月期间接受肝胆超声、剪切波弹性成像和多普勒超声的患者。
  • HARI按标准公式[(PSV-EDV)/PSV]计算,HAVI按[(LSV-ESV)/(PSV-EDV)]计算。
  • 比较不同脂肪变分级间的肝硬度(kPa)、生化参数和FIB-4评分。

诊断标准与关键数值

  • 患者按肝脂肪变分级分为四组。
  • 体重指数、ALT、AST、GGT、总胆固醇和甘油三酯水平随脂肪变严重程度增加而显著升高(p<0.01)。
  • FIB-4在各分级间差异显著(p<0.01),而kPa无显著差异(p=0.11)。
  • HAVI值随脂肪变严重程度增加而显著升高(p<0.01),HARI无差异。
  • HAVI与kPa呈强正相关(r=0.66,p<0.01),与ALT、AST、GGT呈中度相关;HAVI与血小板计数、白蛋白或甘油三酯无显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a common cause of chronic liver disease, and non-invasive methods are essential for evaluating hepatic steatosis and fibrosis. This study aimed to investigate the relationship between the hepatic artery augmented velocity index (HAVI) and the severity of hepatic steatosis and fibrosis in patients with MAFLD.

METHODS: This retrospective study included 197 patients who underwent hepatobiliary ultrasonography (US), shear wave elastography (SWE), and Doppler US between January 2021 and November 2023. HARI was calculated using the standard formula [(PSV - EDV)/PSV], while HAVI was calculated as [(LSV - ESV)/(PSV - EDV)]. Liver stiffness (kPa), biochemical parameters, and the FIB-4 score were compared among steatosis grades.

RESULTS: Patients were divided into four groups based on hepatic steatosis grade. Body mass index, ALT, AST, GGT, total cholesterol, and triglyceride levels increased significantly with steatosis severity (p < 0.01). FIB-4 differed significantly between grades (p < 0.01), whereas kPa did not show a significant difference (p = 0.11). HAVI values increased significantly with steatosis severity (p < 0.01), while HARI did not differ. HAVI showed strong positive correlations with kPa (r = 0.66, p < 0.01) and moderate correlations with ALT, AST, and GGT. No significant correlations were found between HAVI and platelet count, albumin, or triglycerides.

CONCLUSIONS: HAVI showed significant associations with steatosis severity and non-invasive fibrosis markers, whereas no such relationships were observed for HARI in this study. These preliminary findings suggest that HAVI could be further investigated as a potential Doppler-derived parameter to support non-invasive evaluation of liver parenchymal and microvascular alterations in patients with MAFLD.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Yavaş HG, Emekli E, Korkmaz M, et al. Hepatic artery augmented velocity index and steatosis/fibrosis in MAFLD. Abdom Radiol (NY). 2025. PMID: 41047395. doi:10.1007/s00261-025-05225-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。